BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 3333146)

  • 1. A double-blind study of Inderex in the treatment of essential hypertension.
    Crowe PF; Finnegan OC; Russell CJ; Varma MP
    Br J Clin Pract; 1987 Oct; 41(10):967-70. PubMed ID: 3333146
    [No Abstract]   [Full Text] [Related]  

  • 2. "Inderex" therapy in general practice.
    Sanderson JH
    Br J Clin Pract; 1985 Mar; 39(3):98-104. PubMed ID: 3885992
    [No Abstract]   [Full Text] [Related]  

  • 3. The fixed combination of propranolol and bendrofluazide in the treatment of hypertension.
    Jäättelä A
    Ann Clin Res; 1979 Apr; 11(2):80-2. PubMed ID: 378094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind comparison of Inderal LA (160 mg), Half-Inderal LA (80 mg), and Half-Inderal LA plus bendrofluazide (2.5 mg) in the treatment of elderly hypertensive patients.
    Agrawal RL
    Br J Clin Pract; 1987 Sep; 41(9):916-20. PubMed ID: 3330455
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of hypertension with a fixed ratio combination of long-acting propranolol and bendrofluazide, and influence of age of the subject.
    Herrick AL; Davis JM; Weir RJ
    Br J Clin Pract; 1989 Jun; 43(6):196-200. PubMed ID: 2597598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Controlled study of the antihypertensive efficacy of the combination of nadolol and bendroflumethiazide with respect to nadolol alone and placebo].
    Cherchi A; Sau F; Mercuro G; Seguro C; Lai O
    Clin Ter; 1985 May; 113(4):301-6. PubMed ID: 3893868
    [No Abstract]   [Full Text] [Related]  

  • 7. The mild hypertension dilemma: results of the British MRC trial.
    Miall WE
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):12S-21S. PubMed ID: 3098929
    [No Abstract]   [Full Text] [Related]  

  • 8. [Docidrazin. Long-term observation with a 3-component antihypertensive agent].
    Degenring FH
    ZFA (Stuttgart); 1983 Mar; 59(8):476-8. PubMed ID: 6407227
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of essential arterial hypertension with nadolol and bendroflumethiazide].
    Marchetta F; Chiarini C; Degli Esposti E; Santoro A; Sturani A; Zuccalà A; Zucchelli P
    Clin Ter; 1983 Aug; 106(3):209-12. PubMed ID: 6627892
    [No Abstract]   [Full Text] [Related]  

  • 10. Verapamil SR and propranolol LA: a comparison of efficacy and side effects in the treatment of mild to moderate hypertension.
    Bochsler JA; Simmons RL; Ward PJ; Chester PC; Latham AN
    J Hum Hypertens; 1988 Mar; 1(4):305-10. PubMed ID: 3065507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fixed ratio combination of propranolol and bendrofluazide in the treatment of hypertension.
    Pandhi P; Sharma BK; Sharma PL; Wahi PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):92-4. PubMed ID: 3886568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of hypertension with propranolol and bendrofluazide.
    Agrawal RL; Alliott RJ; George M; Gomez G; Trafford JA; Jequier PW; Lishman JD; Turner JR; Baber NS; Dawes PM
    J R Coll Gen Pract; 1979 Oct; 29(207):602-6. PubMed ID: 536969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placebo controlled double-blind randomised cross-over trial of atenolol, hydrochlorothiazide and amiloride, and the combination (Kalten) in patients over 60 years of age.
    Jackson G; Rowland M; Adam G; MacFarlane E; Jackson PG
    Br J Clin Pract; 1986 Jun; 40(6):230-4. PubMed ID: 3527246
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of long-acting propranolol and conventional metoprolol in the treatment of hypertension.
    Jäättelä A; Mäki O
    Ann Clin Res; 1983 Apr; 15(2):45-9. PubMed ID: 6349512
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of hypertension with alpha blockade or ACE inhibition. Multicenter double-blind study of urapidil versus captopril].
    Rosenthal J; Haerlin R
    Fortschr Med; 1986 Oct; 104(40):763-6. PubMed ID: 3536700
    [No Abstract]   [Full Text] [Related]  

  • 16. ["Viskaldix" in the treatment of arterial hypertension].
    Bar-Andziak E; Brym E; Czerniewska E
    Kardiol Pol; 1984; 27(2):125-30. PubMed ID: 6374243
    [No Abstract]   [Full Text] [Related]  

  • 17. Double-blind cross-over clinical trial of acebutolol and propranolol in mild to moderate essential hypertension.
    Pandhi P; Sethi V; Sharma BK; Wahl PL; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):606-8. PubMed ID: 3908332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised double blind cross over trial of atenolol and propranolol in mild to moderate hypertension.
    Mahajan V; Puri R; Gattani RK; Chatterji T
    J Assoc Physicians India; 1987 Jun; 35(6):431-2. PubMed ID: 3308837
    [No Abstract]   [Full Text] [Related]  

  • 19. [The Kristepin and obzidan treatment of patients with hypertension].
    Leviashvili BI
    Vrach Delo; 1989 Jun; (6):39-40. PubMed ID: 2506697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Labetalol in mild and moderate hypertension. A report from the General Practitioner Research Group.
    Practitioner; 1980 Sep; 224(1347):945-9. PubMed ID: 7003576
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.